Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Breast Neoplasms 2Stomatitis 1Radiation Induced Xerostomia 1Radiation Fibrosis Syndrome 1Oral Ulcer 1Lymphedema 1Head and Neck Neoplasms 1Graft vs Host Disease 1

Interventions

Cyclophosphamide 7Mycophenolic Acid 6Tacrolimus 5Busulfan 4ruxolitinib 3fludarabine phosphate 3fludarabine 3Whole-Body Irradiation 3Melphalan 3Thiotepa 2Specimen Handling 2Sirolimus 2Cyclosporine 2belumosudil 1axatilimab 1Stem Cell Transplantation 1Peripheral Blood Stem Cell Transplantation 1Panobinostat 1Methotrexate 1Low-Level Light Therapy 1Leukocyte Count 1Hematopoietic Stem Cell Transplantation 1Etoposide 1Emapalumab 1Drug Therapy 1Clofarabine 1Clinical Trials, Phase I as Topic 1Biopsy 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Graft vs Host Disease × Low-Level Light Therapy × 90 days × Clear all
NCT05675930 2026-05-22

A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

Memorial Sloan Kettering Cancer Center

Phase 2 Recruiting
44 enrolled

Graft vs Host Disease

Data powered by HemOnc (CC BY 4.0) Colophon âš¡